Ping An Insurance (Group) Company of China and Japan’s Shionogi and Company have launched Ping An-Shionogi, a healthcare-as-a-service (HaaS) enterprise, an integrated medical and healthcare platform for public health and patients, in Shanghai.

The joint venture (JV) is a collaboration between the Ping An and Shionogi in drug research, development, production and sales, based on Ping An's healthcare ecosystem and advanced digital technology, and Shionogi's strengths in drug research and development.

Ping An-Shionogi will provide customers with personalized health management solutions, including exercise suggestions, medical prescriptions on over-the-counter drugs, vaccines, new drugs for different stages of healthcare including disease prevention, diagnosis, medical prescription and follow-up visits.

Ping An-Shionogi will build a new drug production system and implement the first digital management mechanism for pharmaceutical manufacturing in China. It will automate instructions and maintain digital records in the pharmaceutical production process and speed up drug development to enhance the quality and efficiency of medical and healthcare services.

“Ping An-Shionogi will integrate Ping An's artificial intelligence technology with Shionogi's research experience in drug development to transform the landscape of the pharmaceutical industry and promote the health of Chinese citizens,” says Tatsumori Yoshida, chairman and CEO of Ping An-Shionogi. "We will fulfil the increasing need for healthcare services and strive for a better society by relentlessly upgrading our service."